Spots Global Cancer Trial Database for Palliative Radiotherapy Protocol in Head and Neck Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Palliative Radiotherapy Protocol in Head and Neck Cancer

Official Title: Palliative Radiotherapy for Advanced Head and Neck Carcinomas, a Phase II Study

Study ID: NCT02460471

Conditions

Head and Neck Neoplasms

Quality of Life

Interventions

palliative radiation therapy

Study Description

Brief Summary: Phase II prospective study or Palliative Radiotherapy of 25 Gy in 5 fractions, Intensity Modulated, for frail patients with incurable head and neck cancer. Comprehensive Quality of life (QLQ-C30, head and neck module, QLQ C15 PAL) and toxicity data (CTCAE v 4.0) collected.

Detailed Description: Patients deemed too frail for radical treatment or incurable because of tumour extension, as determined by an experienced tumour board, were eligible for this study of palliative radiotherapy delivered by intensity modulation, 25 Gy in 5 daily fractions over one week. This study was conducted in two academic centers.